✦ LIBER ✦
Does a rise in the BCR-ABL1 transcript level identify chronic phase CML patients responding to imatinib who have a high risk of cytogenetic relapse?
✍ Scribed by David Marin; Jamshid S. Khorashad; Letizia Foroni; Dragana Milojkovic; Richard Szydlo; Alistair G. Reid; Katayoun Rezvani; Marco Bua; John M. Goldman; Jane F. Apperley
- Book ID
- 108676251
- Publisher
- John Wiley and Sons
- Year
- 2009
- Tongue
- English
- Weight
- 60 KB
- Volume
- 145
- Category
- Article
- ISSN
- 0007-1048
No coin nor oath required. For personal study only.